Obesity Treatment Market Is Predicted To Grow Swiftly Due To Rising Awareness About The Different Bariatric Surgeries Till 2024: Grand View Research, Inc.
The
global obesity treatment market is expected to reach USD
15.6 billion by 2024, according to a new report by Grand View Research, Inc.
Upward trend in sedentary lifestyles, physical inactivity, and unhealthy food
habits are the vital factors responsible for the high prevalence of obesity.
According to the Institute of Health Metrics and Evaluation, about 30.0% of the
global population is either obese or overweight.
Additionally,
along with commercial availability of solutions for weight management,
technological advancements introduced by the vertical players and supportive
initiatives undertaken by the governments, create more awareness with regard to
obesity and its impact on health. This is further driving the growth of the
obesity treatment market.
Global Obesity Treatment Market, 2014 - 2024 (USD Million) |
There
are various approaches for weight management such as diet, exercise, drugs,
minimally invasive devices & implants, and surgeries. Amongst the prevalent
drugs, the combination drugs hold the largest market share whereas satiety
drugs that provide a feeling of fullness appear as the fastest growing segment
in the obesity treatment market.
In
surgeries, gastric bypass procedures form the largest growing segment whereas
the minimally invasive endoscopic procedure segment that involves surgical placement
of implants and devices, such as satiety devices and gastric empting devices,
is the fastest growing space.
Intense
competition in the private sector has driven advancements and innovation toward
the development of the latest techniques for obesity treatment that are offered
in private hospitals and clinics. As a result, the demand for minimally
invasive procedures is swiftly increasing. In addition, increasing awareness of
obesity & the associated diseases and the commercial availability of weight
management solutions is propelling the obesity treatment market.
Browse full
research report on Obesity Treatment Market: www.grandviewresearch.com/industry-analysis/obesity-treatment-devices-and-therapeutics-market
Further key
findings from the report suggest:
- The
combination drugs segment for obesity captured the largest market share of
around 53% of the global market in 2015. The largest share of the segment
was mainly attributed to the rising prevalence of obesity and the
synergistic effect of combination therapy in weight management.
- In the
surgeries and devices segment, gastric bypass is the largest growing with
a market share of over 32%, while the minimally invasive endoscopic
procedures segment is anticipated to be the fastest growing category in
obesity treatment for the forecast period
- North
America accounts for the largest market share of around 52.0% in 2015.
This region is expected to maintain its dominance throughout the forecast
period due to the heavy R&D investments deployed to develop effective
weight management solutions and the commercial availability of minimally
invasive procedures.
- Asia
Pacific is anticipated to witness the fastest growth during the forecast
period. Growing awareness of adverse health effects related to excess
weight and its impact amongst individuals, rising disposable income,
improving healthcare infrastructure, and the emerging medical tourism
industry are some of the factors expected to drive the growth of the Asia
Pacific sector during the forecast period.
- Some
key market participants include VIVUS, Inc., Arena Pharmaceuticals, Inc.,
F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Allergan Plc, Medtronic,
Ethicon (subsidiary of Johnson & Johnson), Cousin Biotech,
EnteroMedics, Inc., and USGI Medical, Inc.
- The
players are focusing on product innovation through extensive R&D
activities and introducing new combination drugs & satiety products.
In addition, the sector giants are developing minimally invasive
procedures and initiating collaborations to expand their geographical territories
to gain greater market presence.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the obesity treatment market on
the basis of product, application, and geography.
Global Obesity Treatment Market Drugs Outlook (Revenue, USD
Million, 2013 - 2024)
- Combination
Drugs
- Appetite
Suppressants
- Malabsorption
- Satiety
Global Obesity Treatment Market Surgery & Devices Outlook
(Revenue, USD Million, 2013 - 2024)
- Adjusting
Gastric Banding
- Roux-en-Y
Gastric Bypass
- Sleeve
Gastrectomy
- Biliopancreatic
Diversion With Duodenal Switch
- Endoscopic
Procedures
- Others
Obesity Treatment Market Regional Outlook (Revenue, USD Million,
2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-obesity-treatment-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment